The challenge of creating labels for investigational drugs is mounting as more countries sign on to participate in clinical trials. Delays in translating and approving clinical labels—a process that averages about 120 business days—can prevent clinical trials from starting on time and threaten to derail development timelines.
Download this ebook to learn about: